MPC-7869

· Myrexis Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for MPC-7869, covering 2008-08-05 to 2009-05-05. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy Study of MPC-7869 to Treat Patients With Alzheimer's [Phase 3]